NIH HEAL Initiative Budget
Fiscal Years 2019-2022 Budget*
HEAL funds 42 distinct research programs, which are led by most NIH Institutes, Centers, and Offices.
Translation of Research to Practice for the Treatment of Opioid Addiction
- HEALing Communities Study | 343.7M
- Enhancing NIDA Clinical Trial Network to Address Opioids | 190.3M
- Justice and Community Opioid Innovation Network (JCOIN) | 128.2M
- Behavioral Research to Improve MAT (BRIM) | 38.4M
- Recovery Research Networks | 13.8M
- Harm Reduction Approaches to Reduce Overdose Death | 19.7M
- Improving Delivery of Healthcare Services for Polysubstance Use | 16M
- The Continuum of Care in Hospitalized Patients with Opioid Use Disorder and Infectious Complications of Drug Use (CHOICE) | 2.3M
New Strategies to Prevent and Treat Opioid Addiction
- Optimizing Care for People with OUD and Mental Health Conditions | 63.8M
- Preventing Opioid Use Disorder (Prevention) | 65.5M
- Sleep Dysfunction as a Core Feature of Opioid Use Disorder and Recovery | 25.6M
- Optimizing the Duration, Retention, and Discontinuation of Medication Treatment for Opioid Use Disorder - CTN | 48.2M
- Prevention of Progression to Moderate or Severe Opioid Use Disorder (STOP) Subsyndromal | 12.5M
- Collaborative Care for Polysubstance Use in Primary Care Settings (Co-Care) | 3.4M
- Monthly Injectable Buprenorphine for Methamphetamine Use Disorder (MURB) | 2.5M
Enhanced Outcomes for Infants and Children Exposed to Opioids
- Advancing Clinical Trials in Neonatal Opioid Withdrawal (ACT NOW) | 69.4M
- HEALthy Brain and Child Development Study (HBCD) | 38.3M Phase II
Novel Therapeutic Options for Opioid Use Disorder and Overdose
- Focusing Medication Development to Prevent and Treat Opioid Use Disorder and Overdose | 420M
- Development of Novel Immunotherapies for Opioid Addiction | 41.4M
Clinical Research in Pain Management
- Back Pain Consortium Research Program (BACPAC) | 134.7M
- Pain Management Effectiveness Research Network (ERN) | 90.9M
- Pragmatic and Implementation Studies for the Management of Pain to Reduce Opioid Prescribing (PRISM) | 40.4M
- Early Phase Pain Investigation Clinical Network (EPPIC-Net) | 52.3M
- Integrated Approach to Pain and Opioid Use in Hemodialysis Patients (HOPE) | 28.4M
- Integrative Management of Chronic Pain and OUD for Whole Recovery (IMPOWR) | 20.6M
- Advancing Health Equity in Pain Management | 15.4M
- Discovery and Validation of Biomarkers, Endpoints and Signatures for Pain Conditions | 46.3M
Preclinical and Translational Research in Pain Management
- Discovery and Validation of Novel Targets for Safe and Effective Treatment of Pain | 90.3M
- Preclinical Screening Platform for Pain (PSPP) | 43.4M
- Translational Research to Advance Testing of Novel Drugs and Human Cell-Based Screening Platforms to Threat Pain and Opioid Use Disorder | 119.2M
- Translating Discoveries to Devices for Effective Pain Treatment | 51.5M
- Development and Optimization of Non-Addictive Therapies to Treat Pain | 55.3M
- Restoring Joint Health and Function to Reduce Pain Consortium (RE-JOIN) | 31.1M
Cross-Cutting Research
- Increasing Participant Diversity, Inclusion and Engagement in HEAL | 14.8M
- Training the Next Generation of Researchers in HEAL | 18.1M
- Leveraging Existing and Real-Time Opioid and Pain Management Data | 53.1M
- Translating Data 2 Action to Prevent Overdose | 12.1M
- Stigma in Pain Management and Opioid Use Disorder | 1.6M
- Small Business Programs | 93.4M
*The Acute to Chronic Pain Signatures and Stimulating Peripheral Activity to Relieve Conditions (SPARC) programs are supported by the NIH Common Fund and do not appear on this page.